tiprankstipranks
Kura Oncology price target lowered to $18 from $22 at Scotiabank
PremiumThe FlyKura Oncology price target lowered to $18 from $22 at Scotiabank
1M ago
Kura Oncology price target lowered to $34 from $37 at Wedbush
Premium
The Fly
Kura Oncology price target lowered to $34 from $37 at Wedbush
1M ago
Kura selling off on loss of acquisition premium, says TD Cowen
Premium
The Fly
Kura selling off on loss of acquisition premium, says TD Cowen
1M ago
Kura Oncology, Kyowa Kirin to develop and commercialize ziftomenib in leukemias
PremiumThe FlyKura Oncology, Kyowa Kirin to develop and commercialize ziftomenib in leukemias
1M ago
Leerink views Syndax data as potentially positive for Kura Oncology’s ziftomenib
Premium
The Fly
Leerink views Syndax data as potentially positive for Kura Oncology’s ziftomenib
1M ago
Kura Oncology Advances Cancer Treatment Pipeline
Premium
Company Announcements
Kura Oncology Advances Cancer Treatment Pipeline
1M ago
Kura Oncology reports preclinical data on ziftomenib
PremiumThe FlyKura Oncology reports preclinical data on ziftomenib
2M ago
Kura Oncology initiated with a Buy at UBS
Premium
The Fly
Kura Oncology initiated with a Buy at UBS
2M ago
Kura Oncology presents new data on KO-2806 with targeted therapies
Premium
The Fly
Kura Oncology presents new data on KO-2806 with targeted therapies
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100